AnaptysBio: SGS Achieves ISO 45001 Accreditation to Enhance Workplace Safety Initiatives
- SGS has achieved ISO 45001 accreditation, enhancing its certification offerings for businesses prioritizing workplace safety.
- The accreditation supports organizations in North America to integrate ISO 45001 with other SGS standards for safety management.
- SGS's ISO 45001 certification aligns with its commitment to improving health and safety practices across various sectors.
Strengthening Workplace Safety Initiatives: SGS Achieves ISO 45001 Accreditation
SGS, a global leader in testing, inspection, and certification, has recently secured accreditation from the ANSI National Accreditation Board (ANAB) for ISO 45001:2018 Occupational Health & Safety Management Systems. This significant development allows SGS to offer independent, third-party assessments to businesses pursuing ISO 45001 certification. This international standard is pivotal for organizations striving to effectively manage and mitigate health and safety risks in the workplace. Angela Garner, Vice President of Industrial and Mobility at SGS North America, emphasizes that this new accreditation enhances SGS's certification portfolio, particularly benefiting clients in North America who can now integrate ISO 45001 with other SGS ANAB-accredited standards, such as ISO 9001 and ISO 14001.
The importance of ISO 45001 lies in its emphasis on active worker participation in health and safety decisions, as articulated in clause 5.4 of the standard. This participatory approach not only bolsters workplace safety but also significantly improves an organization’s reputation and employee retention rates. Garner expresses enthusiasm about the potential for SGS to assist a wide range of organizations across North America in achieving this critical certification. By confirming that an organization’s management system aligns with ISO 45001 best practices, SGS reinforces its role in enhancing workplace safety and compliance, which is increasingly vital for businesses that engage with global partners.
Moreover, SGS's ISO 45001 accreditation complements its existing UKAS and SAS accreditations, ensuring that clients can obtain accredited certification regardless of their geographical location. With over 145 years of experience, SGS operates across various sectors, including natural resources, consumer products, pharmaceuticals, and industrial manufacturing. The company holds the largest number of national accreditations globally, positioning itself as a key partner for businesses seeking to meet regulatory compliance and quality assurance standards. By integrating ISO 45001 into its offerings, SGS is poised to further support organizations in their commitment to creating safer workplaces.
In addition to the ISO 45001 accreditation, SGS continues to expand its capabilities in multiple sectors, ensuring that clients can rely on its expertise for comprehensive solutions. The alignment of ISO 45001 with other management systems underlines SGS's commitment to promoting a holistic approach to organizational safety and quality management. As companies increasingly prioritize workplace safety, SGS's accreditation will serve as a valuable asset in navigating the complexities of health and safety regulations.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…

